Skip to main content
OpenTrials
Completed

NCT Number: NCT03916939

Osteopathic Treatment to Alcohol Withdrawal Syndrome

The alcohol withdrawal syndrome has a hierarchical symptomatology depending on the severity (minor, moderate or severe). These signs express a state of psychic, behavioral and physical deprivation.

The management of withdrawal syndrome involves the establishment of pharmacological and psychosocial interventions.

Osteopathy is an exclusively manual practice whose purpose is to overcome the dysfunction of mobility of tissues of the human body. It can be used as a complementary treatment when a specific support is put in place. The purpose of this study is to examine the effectiveness of osteopathy in reducing alcohol withdrawal symptoms in adult patients.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Alcohol Withdrawal

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Chi Creteil

Créteil, 94000, France

About this study

The use of osteopathic techniques for facial equilibration decreases the severity of withdrawal symptoms experienced by patients hospitalized in a weekday hospital.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Age> 18 years
  • Patient hospitalized for a programmed alcohol withdrawal
  • Patient not abstinent with alcohol before hospitalization
  • Signed informed consent

Exclusion criteria

  • Minor patient
  • Patient with an addiction other than alcohol (except tobacco and benzodiazepines)
  • Previous participation in the OSTEOOL study

Treatment and study plan

osteopathy

Other

osteopathy treatment

simulated osteopathy

Other

simulated osteopathic sessions

Primary outcomes

  1. Cushman score (0 to 27)

    Time frame: Day one

    comparison between the two groupe of the cushamn socre between 11:30 am and 00:00 pm. questionary for alcohol dependency

Secondary outcomes

  1. CIWA Ar (Clinicial Institute Withdrawal Assessment - Alcohol Revised) test (0 to 67)

    Time frame: day 0

    comparison between the two groups with this questionary for alcohol withdrawal

  2. CIWA Ar test (0 to 67)

    Time frame: day 1

    comparison between the two groupe with this questionary for alcohol withdrawal

  3. CIWA Ar test (0 to 67)

    Time frame: day 2

    compariason between the two groups with this questionary for alcohol withdrawal

  4. CIWA Ar test (0 to 67)

    Time frame: day 3

    comparison between the two groups with this questionary for alcohol withdrawal

  5. CIWA Ar test (0 to 67)

    Time frame: day 4

    comparison between the two groups with this questionary for alcohol withdrawal

  6. cardiac frequency (beat per minute)

    Time frame: day 1

    mesurement of cardiac frequency and compaaison between the two groups

  7. cardiac frequency (beat per minute)

    Time frame: day 3

    mesurement of cardiac frequency and comparison between the two groups

  8. cardiac frequency (beat per minute)

    Time frame: day 4

    measurement of cardiac frequency and comparison between the two groups

  9. quality sleep scale (0 to 5)

    Time frame: day 0

    comparison between the two groups with sleep score

  10. quality sleep scale (0 to 5)

    Time frame: day 1

    comparison between the two groups with sleep score

  11. quality sleep scale (0 to 5)

    Time frame: day 2

    comparison between the two groups with sleep score

  12. quality sleep scale (0 to 5)

    Time frame: day 3

    comparison between the two groups with sleep score

  13. quality sleep scale (0 to 5)

    Time frame: day 4

    comparison between the two groups with sleep score

  14. quantity of benzodiazepine mg per 24 hours

    Time frame: day 2

    comparison between the two groups of benzodiazepin use

  15. quantity of benzodiazepine (mg per 24 hours)

    Time frame: day 3

    comparison between the two groups of benzodiazepin use

  16. quantity of benzodiazepine (mg per 24 hours)

    Time frame: day 4

    comparison betwenn the two groups of benzodiazepin use

  17. Cushmamn score (0 to 27)

    Time frame: day 3

    comparison between the two groups of the Cushamn score between 11:30 am and 00:00 pm

Sponsors and collaborators

Lead sponsor

Centre Hospitalier Intercommunal Creteil

Other

Collaborators

  • Ecole Supérieur d'Ostéopathie

Registry information

Official study title

Contribution of Osteopathic Treatment to Alcohol Withdrawal Syndrome in Hospitalized Adult Patients

Acronym: OSTEOOL

Important dates

Study start
2018
Primary completion
2024
Study completion
2024
First posted
Apr 16, 2019
Registry last updated
Jun 15, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.